| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | 1 | — | — | — | — | — | — | — | — |
| Sell | — | — | 2 | — | — | — | — | 1 | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 37.00 | 40.00 | 44.00 | 37.00 |
| Receivables | 889.00 | 953.00 | 1,093.00 | 921.00 |
| Inventory | 2,292.00 | 2,179.00 | 2,095.00 | 1,946.00 |
| Other | 242.00 | — | — | — |
| 3,463.00 | 3,402.00 | 3,423.00 | 3,138.00 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 1,781.00 | 1,688.00 | 1,875.00 | 1,771.00 |
| ST’ Debt | 18.00 | 11.00 | 8.00 | 5.00 |
| Other | 426.00 | — | — | — |
| 2,405.00 | 2,365.00 | 2,602.00 | 2,438.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 7,840.00 | 7,947.00 | 7,723.00 | 7,642.00 |
31,152.00
|
| ’25 | 7,871.00 | 8,158.00 | 8,059.00 | 7,696.00 |
31,784.00
|
| ’24 | 7,552.00 | 7,775.00 | 7,498.00 | 8,155.00 |
30,980.00
|
| ’23 | 7,532.00 | 7,816.00 | 7,507.00 | 7,417.00 |
30,272.00
|
| ’22 | 6,997.00 | 7,416.00 | 7,242.00 | 7,273.00 |
28,928.00
|
| ’21 | 6,684.00 | 6,900.00 | 6,631.00 | 6,735.00 |
26,950.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (38.00) | 283.00 | 98.00 | 197.00 |
540.00
|
| ’25 | (110.00) | 247.00 | 173.00 | 160.00 |
470.00
|
| ’24 | (254.00) | 183.00 | 125.00 | 199.00 |
253.00
|
| ’23 | (262.00) | 532.00 | 132.00 | 222.00 |
624.00
|
| ’22 | (81.00) | 124.00 | (74.00) | 362.00 |
331.00
|
| ’21 | (58.00) | 265.00 | 129.00 | 278.00 |
614.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (54.00) | 254.00 | 56.00 | 123.00 |
379.00
|
| ’25 | (155.00) | 194.00 | 120.00 | 110.00 |
269.00
|
| ’24 | (319.00) | 118.00 | 52.00 | 82.00 |
(67.00)
|
| ’23 | (322.00) | 453.00 | 67.00 | 119.00 |
317.00
|
| ’22 | (136.00) | 76.00 | 102.00 | 268.00 |
310.00
|
| ’21 | (95.00) | 251.00 | 72.00 | 158.00 |
386.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (0.06) | 0.31 | 0.52 | 0.57 |
1.34
|
| ’25 | (0.35) | (0.05) | (0.12) | (1.43) |
(1.95)
|
| ’24 | (0.67) | (0.25) | (0.34) | (0.63) |
(1.89)
|
| ’23 | 1.07 | 0.31 | 0.12 | (1.15) |
0.40
|
| ’22 | 1.25 | 1.08 | 1.10 | 0.63 |
4.07
|
| ’21 | (0.02) | 1.00 | 0.80 | 0.69 |
2.48
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 32.90 | 12.88 | 8.58 | 20.78 | 32.06 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.81 | 43.95 | 32.20 | 43.29 | 57.02 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30,300 | 29,455 | 28,333 | 25,600 | 23,431 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.95 | 1.03 | 1.09 | 1.24 | 1.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28,928.00 | 30,272.00 | 30,980.00 | 31,784.00 | 31,152.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.46% | 13.65% | 13.56% | 13.28% | 13.47% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 310.00 | 7.00 | (137.00) | (154.00) | 102.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.07% | 0.02% | (0.44%) | (0.48%) | 0.33% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 254.00 | 30.00 | (110.00) | (115.00) | 84.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 285.00 | 304.00 | 319.00 | 321.00 | 303.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 498.76 | 511.35 | 522.43 | 527.97 | 513.21 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.28 | 0.41 | (1.89) | (1.95) | 1.39 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.71 | 10.54 | 4.27 | 7.81 | 8.90 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.36) | (5.19) | (5.40) | (3.34) | (2.65) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.34 | 5.35 | (1.13) | 4.47 | 6.24 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.90 | 29.46 | 27.67 | 25.81 | 26.72 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 58.00 | 59.20 | 59.30 | 60.20 | 60.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 10.10 | 50.73 | 0.00 | 0.00 | 36.57 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.09 | 0.04 | 0.03 | 0.05 | 0.10 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.40 | 0.71 | 0.56 | 1.07 | 1.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.16 | 0.11 | 0.10 | 0.11 | 0.15 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.91 | 10.03 | (44.52) | 13.00 | 12.20 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 331.00 | 624.00 | 253.00 | 470.00 | 540.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (21.00) | (307.00) | (320.00) | (201.00) | (161.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 310.00 | 317.00 | (67.00) | 269.00 | 379.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,380.00 | 1,058.00 | 1,037.00 | 821.00 | 700.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,159.00 | 1,986.00 | 2,104.00 | 1,878.00 | 1,576.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,115.00 | 1,949.00 | 2,064.00 | 1,834.00 | 1,539.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,792.00 | 1,744.00 | 1,641.00 | 1,554.00 | 1,622.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.27% | 0.32% | (1.50%) | (1.56%) | 1.14% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.77% | 2.03% | 0.13% | (0.57%) | 4.17% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.00% | 1.36% | (6.62%) | (7.39%) | 5.29% | — | — | — |
ROE
|
United Natural Foods (UNFI) has bulked up into a $30B+ revenue behemoth since its 2018 Supervalu acquisition, delivering a stellar 12% CAGR through 2028 amid natural foods tailwinds—but at a brutal cost. Gross margins have eroded from 15% to a projected 13%, fueling wild profitability swings: from $310M EBT highs to -$154M lows, with free cash flow flipping negative on capex binges for e-commerce upgrades. Stock volatility mirrors this chaos, plunging 78% in crashes despite revenue tripling, now trading at consensus targets that scream “cautious stability” rather than breakout potential.
Balance sheet deleveraging shines—debt down 38%, equity stabilizing—yet ROE and ROIC limp toward breakeven, and book value per share lags 29% behind peaks. Analysts bet on a sharp inflection with EPS doubling to $3.27 by 2028 and FCF rebounding, fueled by plant-based demand and efficiencies. But contrarians beware: persistent inflation, labor squeezes, and competition from KeHE/Sysco could keep margins crushed in this razor-thin industry.
Insider buys hint at turnaround confidence amid modest sells, positioning UNFI for asymmetric upside if execution clicks in a consolidating niche. Skeptics, though, see fair value at best—dive deeper to weigh if revenue scale finally trumps the margin trap.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.